Dagan R, Abramson O, Leibovitz E, Lang R, Goshen S, Greenberg D, Yagupsky P, Leiberman A, Fliss D M
Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Pediatr Infect Dis J. 1996 Nov;15(11):980-5. doi: 10.1097/00006454-199611000-00010.
Penicillin resistance of Streptococcus pneumoniae, one of the most common causes of acute otitis media, has recently increased and is now highly prevalent in many regions. However, its contribution to clinical failure still must be proved. Because the role of antibiotics in acute otitis media is to eradicate the pathogens present in the middle ear fluid, we conducted a randomized controlled study to determine bacterial eradication of pathogens in acute otitis media by two commonly used oral cephalosporins, cefuroxime axetil (30 mg/kg/day) and cefaclor (40 mg/kg/day).
Patients 6 to 36 months old with pneumococcal otitis media seen in the Pediatrics Emergency Room were studied. An initial middle ear fluid culture was obtained at enrollment, and a second culture was obtained on Day 4 or 5 during treatment. Follow-up was done also on Days 10, 17 and 42 after initiation of treatment. In cases of clinical relapse a third culture was obtained.
In total 78 patients were enrolled, 41 in the cefuroxime axetil group and 37 in the cefaclor group. Of the 78 S. pneumoniae isolates 31 (40%) were intermediately penicillin-resistant (MIC 0.125 to 1.0 microgram/ml). Of the 47 patients with penicillin-susceptible organisms 3 (6%) had bacteriologic failure vs. 4 of 19 (21%) and 7 of 11 (64%) of those with MIC of 0.125 to 0.25 microgram/ml and 0.38 to 1.0 microgram/ml, respectively (P < 0.001). For intermediately resistant pneumococci, in 7 of 12 (58%) of those receiving cefaclor the isolate was not eradicated vs. only 4 of 19 (21%) of those receiving cefuroxime axetil (P = 0.084). MIC to the administered cephalosporin of > 0.5 microgram/ml was associated with bacteriologic failure. Clinical failure was observed in 9 of 14 (64%) patients with bacteriologic failure vs. 10 of 52 (19%) patients with bacteriologic eradication (P = 0.003).
Intermediately penicillin-resistant S. pneumoniae is associated with an impaired bacteriologic and clinical response of acute otitis media to cefaclor and cefuroxime axetil. This effect was more pronounced with cefaclor than with cefuroxime axetil.
肺炎链球菌是急性中耳炎最常见的病因之一,其对青霉素的耐药性近来有所增加,目前在许多地区高度流行。然而,其对临床治疗失败的影响仍有待证实。由于抗生素在急性中耳炎中的作用是根除中耳液中存在的病原体,我们进行了一项随机对照研究,以确定两种常用口服头孢菌素头孢呋辛酯(30毫克/千克/天)和头孢克洛(40毫克/千克/天)对急性中耳炎病原体的细菌清除情况。
对在儿科急诊室就诊的6至36个月大的肺炎球菌性中耳炎患者进行研究。在入组时获取初始中耳液培养物,并在治疗期间的第4天或第5天获取第二次培养物。在治疗开始后的第10天、第17天和第42天也进行随访。对于临床复发的病例,获取第三次培养物。
总共纳入了78例患者,头孢呋辛酯组41例,头孢克洛组37例。在78株肺炎链球菌分离株中,31株(40%)对青霉素中度耐药(最低抑菌浓度为0.125至1.0微克/毫升)。在47例青霉素敏感菌患者中,3例(6%)出现细菌学治疗失败,而最低抑菌浓度为0.125至0.25微克/毫升和0.38至1.0微克/毫升的患者中,分别有4例(21%)和7例(64%)出现细菌学治疗失败(P<0.001)。对于中度耐药的肺炎球菌,接受头孢克洛治疗的12例患者中有7例(58%)分离株未被清除,而接受头孢呋辛酯治疗的19例患者中只有4例(21%)分离株未被清除(P = 0.084)。对所用头孢菌素的最低抑菌浓度>0.5微克/毫升与细菌学治疗失败相关。在14例细菌学治疗失败的患者中有9例(64%)出现临床治疗失败,而在52例细菌学清除的患者中有10例(19%)出现临床治疗失败(P = 0.003)。
中度青霉素耐药的肺炎链球菌与急性中耳炎对头孢克洛和头孢呋辛酯的细菌学及临床反应受损有关。这种影响在头孢克洛组比在头孢呋辛酯组更明显。